Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pancreatic cancer
pancreatic cancer
Gilead's oncology contender comes up short in pancreatic cancer
Fierce Biotech
Wed, 09/17/14 - 09:54 am
Gilead Sciences
simtuzumab
pancreatic cancer
Halozyme's PEGPH20 Program Gains Fast Track Designation
Yahoo/Zacks
Sat, 09/6/14 - 09:18 am
Halozyme
PEGPH20
metastatic pancreatic cancer
pancreatic cancer
OncoMed initiates Phase 2 ALPINE trial of tarextumab
Yahoo/Fly on the Wall
Wed, 07/16/14 - 10:38 am
OncoMed
tarextumab
pancreatic cancer
Abraxane
Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment
Seeking Alpha
Tue, 07/8/14 - 10:03 am
Halozyme
Baxter
Human Immune Globulin Infusion
pancreatic cancer
Incyte's Jakafi Unlikely to Benefit Pancreatic Cancer Patients
TheStreet.com
Wed, 06/11/14 - 10:38 am
Incyte
Jakafi
pancreatic cancer
Immunomedics Inc announces orphan drug designation for IMMU-132 for Pancreatic Cancer Therapy
Reuters
Mon, 06/9/14 - 09:21 am
IMMU-132
orphan drugs
Immunomedics
pancreatic cancer
Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014
Yahoo/BusinessWire
Sun, 06/1/14 - 11:35 am
pancreatic cancer
Abraxane
gemcitabine
Celgene
Immunomedics Reports Final Efficacy Results of Phase Ib Trial With Yttrium-90-Labeled Clivatuzumab Tetraxetan in Patients With Metastatic Pancreatic Cancer
Yahoo/Globe Newswire
Sun, 06/1/14 - 11:31 am
Immunomedics
pancreatic cancer
clivatuzumab tetraxetan
gemcitabine
Three Companies That Want to Cure Pancreatic Cancer
Yahoo/247WallStreet
Thu, 05/22/14 - 10:10 am
pancreatic cancer
Celgene
Abraxane
Incyte
ruxolitinib
Merrimack Pharmaceuticals
MM-398
Is Merrimack Pharmaceuticals Worth More Than $700 Million?
Motley Fool
Mon, 05/5/14 - 05:02 pm
Merrimack Pharmaceuticals
pancreatic cancer
MM-398
Gemzar
Eli Lilly
Celgene
Abraxane
2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals
Motley Fool
Thu, 04/10/14 - 11:13 pm
Merrimack Pharmaceuticals
Sunesis
pancreatic cancer
MM-398
vosaroxin
FDA halts Halozyme's pancreatic cancer study
Yahoo/Reuters
Wed, 04/9/14 - 08:49 am
pancreatic cancer
FDA
Halozyme
Pancreatic Cancer Trial Enrollment Halt Damages Halozyme
Yahoo/247WallStreet
Fri, 04/4/14 - 09:31 am
Halozyme
pancreatic cancer
PEGPH20
Celgene reiterates commitment to improving pancreatic cancer care in Europe
Yahoo/Fly on the Wall
Wed, 03/19/14 - 09:52 am
Celgene
pancreatic cancer
Europe
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule
TheStreet.com
Wed, 02/26/14 - 09:04 am
pancreatic cancer
vaccine
HyperAcute Pancreas
NewLink Genetics
Celgene's Abraxane Under Fire in NEJM Letter
TheStreet.com
Thu, 01/30/14 - 10:10 am
New England Journal of Medicine
Abraxane
Celgene
pancreatic cancer
breast cancer
lung cancer
Positive Oncology News Lifts OncoMed
Yahoo/Zacks.com
Mon, 01/20/14 - 07:00 pm
OncoMed
OMP-59R5
demcizumab
pancreatic cancer
Onconova tanks as its lead candidate flunks PhIII for pancreatic cancer
Fierce Biotech
Wed, 12/18/13 - 12:09 pm
Rigosertib
pancreatic cancer
Onconova
Abraxane's Approval for Pancreatic Cancer Is a Major Milestone for Celgene
Motley Fool
Mon, 09/30/13 - 11:40 am
Celgene
pancreatic cancer
Abraxane
TESARO Describes Initial Phase 1 Clinical Data for TSR-011 Presented at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sun, 09/29/13 - 01:35 pm
TSR-011
pancreatic cancer
Tesaro
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »